{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-21-002989","form_type":"8-K","ticker":"CPMD","cik":"0001081938","company_name":"CANNAPHARMARX, INC.","filed_at":"2021-07-16T23:59:59+00:00","discovered_at":"2026-05-14T18:04:17.094184+00:00","generated_at":"2026-06-30T04:43:31.981659+00:00","sec_items":["1.01","7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"CannaPharmaRx sells Hanover facility for $2M CAD to reduce debt","bullets":["Sold Hanover, Ontario facility for $2,000,000 CAD, including 10 acres and 48,800 sq ft of growing space.","Sale unanimously approved by senior management; proceeds to eliminate debt and liabilities.","CEO Nick Colvin states sale will 'vastly improve the bottom line of our balance sheet'.","Company cites focus on more technologically advanced facilities as reason for divestiture."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-21-002989","json":"https://secwatch.observer/filing/0001683168-21-002989.json","markdown":"https://secwatch.observer/filing/0001683168-21-002989.md","text":"https://secwatch.observer/filing/0001683168-21-002989.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1081938/000168316821002989/0001683168-21-002989-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1081938/000168316821002989/cannapharma_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-30T04:43:31.981659+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}